172 Stage and Survival of Screen Detected Small Cell Lung Cancer from the SUMMIT Study

Small cell lung cancer (SCLC) accounts for 15% of lung cancers with 30% of diagnoses at limited stage and 70% at extensive stage. The median survival is 15 and 6.2 months for limited and extensive stage SCLC respectively. Low dose Computed Tomography (LDCT) screening has not typically been thought to provide a survival benefit in SCLC.